Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
for Muscle Invasive Bladder Urothelial Carcinoma
Sites in Duarte +4 more locations
Sponsor: Matthew Galsky
Sex: All·Age: 18+
Code: NCT06809140·Phase 2·Recruiting·Listed Feb 2025